Healthcare - Biotechnology - NASDAQ - US
$ 0.9469
-9.82 %
$ 78 M
Market Cap
-0.56
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
20.65%
Net Income
Estimate
23.21%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Adicet Bio, Inc.
ACET has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ACET
EBIT FORECAST
EBIT Forecast Chart ACET
NET INCOME FORECAST
Net Income Chart ACET